0.208
-0.007 (-3.26%)
-0.007 (-3.26%)
Upgrade to Real-Time
Afterhours
| Volume | 761,053 |
|
|||||
| News | (1) | ||||||
| Day High | 0.21 | Low High |
|||||
| Day Low | 0.19 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ENDRA Life Sciences Inc | NDRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.007 | -3.26% | 0.208 | 16:08:47 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.198 | 0.19 | 0.21 | 0.208 | 0.215 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 986 | 761,053 | $ 0.2038262 | $ 155,123 | - | 0.18 - 2.44 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:26:43 | 55 | $ 0.21 | USD |
Period:
Draw Mode:
ENDRA Life Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 13.14M | 63.17M | 62.31M | $ - | $ - | -0.28 | -0.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 2.09M | 2.40% |
ENDRA Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NDRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.205 | 0.29 | 0.19 | 0.2339451 | 1,925,850 | 0.003 | 1.46% |
| 1 Month | 0.257 | 0.299899 | 0.18 | 0.2268494 | 1,695,105 | -0.049 | -19.07% |
| 3 Months | 0.42 | 0.649 | 0.18 | 0.295194 | 2,984,914 | -0.212 | -50.48% |
| 6 Months | 0.9618 | 1.09 | 0.18 | 0.3320636 | 1,571,766 | -0.7538 | -78.37% |
| 1 Year | 2.11 | 2.44 | 0.18 | 0.6051197 | 943,116 | -1.90 | -90.14% |
| 3 Years | 1.12 | 3.10 | 0.18 | 1.34 | 745,018 | -0.912 | -81.43% |
| 5 Years | 3.985 | 5.88 | 0.18 | 1.52 | 525,297 | -3.78 | -94.78% |
ENDRA Life Sciences Description
| ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. |